How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
The novel oral anticoagulants or direct oral anticoagulants (DOAC) are becoming more common in clinical practice for the prevention of stroke in non-valvular atrial fibrillation (NVAF). The availability of several agents with similar efficacy and safety for stroke prevention in NVAF patients offers...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Berlin Heidelberg
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742513/ |